These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of p-aminohippurate and pyrazinoate on the renal excretion of salicylate in the rat: a micropuncture study.
    Author: Ferrier B, Martin M, Roch-Ramel F.
    Journal: J Pharmacol Exp Ther; 1983 Feb; 224(2):451-8. PubMed ID: 6822966.
    Abstract:
    The inhibitory effects of p-aminohippurate and pyrazinoate (PZA) on the transport of salicylate were studied by free-flow micropuncture in the rat. p-Aminohippurate (5, 10 or 25 mumol/kg X min) and PZA (10 or 25 mumol/kg X min) inhibited proximal tubular secretion of salicylate; they induced decreases in the fractional delivery of salicylate to the late proximal tubules. In alkalotic rats, the late proximal decrease in fractional delivery of salicylate was accompanied by a decreased fractional excretion of salicylate. In contrast, such a decrease in fractional excretion of salicylate was not observed in rats in normal acid-base balance. A greater rate of PZA infusion (25 mumol/kg X min) not only inhibited secretion, but also depressed a reabsorptive carrier-mediated transport of salicylate. Thus, in alkalotic rats, fractional delivery of salicylate to late proximal tubules were 1.90 +/- 0.15, 0.90 +/- 0.10 and 1.34 +/- 0.13, respectively, for control rats and rats infused with 10 or 25 mumol/kg X min of PZA. The corresponding values of fractional excretion of salicylate were 1.21 +/- 0.09, 0.61 +/- 0.05 and 0.08 +/- 0.09, respectively. The data suggest that salicylate is secreted as well as reabsorbed by carrier-mediated mechanisms and that there may be two secretory mechanisms.
    [Abstract] [Full Text] [Related] [New Search]